The Vice Presidents team at Immunovant comprises leaders responsible for specialized functions crucial to the company's success in developing and marketing treatments for autoimmune diseases. They oversee quality control, biostatistics, financial planning, drug safety, regulatory affairs, SEC reporting, marketing, process development, investor relations, IT, and human resources, ensuring cohesive strategy execution and regulatory compliance across the organization.
View all